Educational issues in clinical pharmacology: who are our audiences and what are their specialized needs? One specialized need: "understanding the role of veterinary medicine in public health".
When considering educational issues and the need to update the curriculum for clinical pharmacologists for the new millennium, a number of questions must be raised. Who are our audiences? What are the specialized needs? This educational article identifies the audience, which includes those with diverse degrees such as MDs, PhDs, PharmDs, RNs, DVMs, and other non-MD prescribers working in academia, industry, clinical research organizations, and government in multifaceted disciplines requiring a knowledge base of physiology, pharmacology, biochemistry, anatomy, microbiology, pathology, medicine, and the drug development process of preclinical and clinical studies complete with protocols, pharmacokinetics, and statistics. One specialized current educational issue for clinical pharmacologists to understand is the impact of animal therapeutic and subtherapeutic use of antimicrobials on antibiotic use in human medicine.
Lathers
Claire M
CM
Office of New Animal Drug Evaluation, Center for Veterinary Medicine, Food and Drug Administration, Rockville, Maryland 20855, USA.
D000820:Animal Diseases / Q000188:drug therapy; D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D004512:Education, Pharmacy; D005544:Forecasting; D006801:Humans; D017145:Models, Educational; D010601:Pharmacology, Clinical / Q000193:education*; D011634:Public Health; D011640:Public Policy; D018570:Risk Assessment / Q000331:legislation & jurisprudence; D012480:Salmonella Infections / Q000188:drug therapy; D014481:United States; D019155:Veterinary Drugs / Q000009:adverse effects / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D019155:Veterinary Drugs; D002443:Ceftriaxone